Conrad, M. et al. Cell death in cancer. Cell 189, 2322–2356 (2026). Article PubMed CAS Google Scholar Mao, C., Jiang, D., Koong, A. C. & Gan, B. Exploiting metabolic cell death for cancer therapy. Nat. Rev. Cancer 26, 27–45 (2026). Article PubMed CAS Google Scholar Amaria, R. N. et al. Neoadjuvant relatlimab and nivolumab in
Conrad, M. et al. Cell death in cancer. Cell 189, 2322–2356 (2026).
Google Scholar
Mao, C., Jiang, D., Koong, A. C. & Gan, B. Exploiting metabolic cell death for cancer therapy. Nat. Rev. Cancer 26, 27–45 (2026).
Google Scholar
Amaria, R. N. et al. Neoadjuvant relatlimab and nivolumab in resectable melanoma. Nature 611, 155–160 (2022).
Google Scholar
Huang, Q. et al. The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodes. Cell 185, 4049–4066 (2022).
Google Scholar
Tawbi, H. A. et al. Relatlimab and nivolumab versus nivolumab in untreated advanced melanoma. N. Engl. J. Med. 386, 24–34 (2022).
Google Scholar
Sharma, P. et al. Immune checkpoint therapy—current perspectives and future directions. Cell 186, 1652–1669 (2023).
Google Scholar
Gulhati, P. et al. Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer. Nat. Cancer 4, 62–80 (2023).
Google Scholar
Abril-Rodriguez, G. et al. PAK4 inhibition improves PD-1 blockade immunotherapy. Nat. Cancer 1, 46–58 (2020).
Google Scholar
Wang, Q. et al. A bioorthogonal system reveals antitumour immune function of pyroptosis. Nature 579, 421–426 (2020).
Google Scholar
Zhang, Z. et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature 579, 415–420 (2020).
Google Scholar
Zhang, T. et al. ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis. Nature 606, 594–602 (2022).
Google Scholar
He, S. & Wang, X. RIP kinases as modulators of inflammation and immunity. Nat. Immunol. 19, 912–922 (2018).
Google Scholar
Li, L. et al. Burst release of encapsulated annexin A5 in tumours boosts cytotoxic T-cell responses by blocking the phagocytosis of apoptotic cells. Nat. Biomed. Eng. 4, 1102–1116 (2020).
Google Scholar
Meier, P., Legrand, A. J., Adam, D. & Silke, J. Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity. Nat. Rev. Cancer 24, 299–315 (2024).
Google Scholar
Yuan, J. & Ofengeim, D. A guide to cell death pathways. Nat. Rev. Mol. Cell Biol. 25, 379–395 (2024).
Google Scholar
Broz, P., Pelegrín, P. & Shao, F. The gasdermins, a protein family executing cell death and inflammation. Nat. Rev. Immunol. 20, 143–157 (2019).
Google Scholar
Gao, W., Wang, X., Zhou, Y., Wang, X. & Yu, Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct. Target. Ther. 7, 196 (2022).
Google Scholar
Su, W. et al. A dual-responsive STAT3 inhibitor nanoprodrug combined with oncolytic virus elicits synergistic antitumor immune responses by igniting pyroptosis. Adv. Mater. 35, e2209379 (2023).
Google Scholar
Wang, Z. et al. Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy. Nat. Nanotechnol. 16, 1130–1140 (2021).
Google Scholar
Chen, B. et al. In situ-generated vaccine-like pyroptosome for personalized cancer immunotherapy. Nat. Mater. 25, 856–867 (2026).
Google Scholar
Vandenabeele, P., Bultynck, G. & Savvides, S. N. Pore-forming proteins as drivers of membrane permeabilization in cell death pathways. Nat. Rev. Mol. Cell Biol. 24, 312–333 (2023).
Google Scholar
Wang, Y. et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature 547, 99–103 (2017).
Google Scholar
Devant, P. & Kagan, J. C. Molecular mechanisms of gasdermin D pore-forming activity. Nat. Immunol. 24, 1064–1075 (2023).
Google Scholar
Kesavardhana, S., Malireddi, R. K. S. & Kanneganti, T.-D. Caspases in cell death, inflammation, and pyroptosis. Annu. Rev. Immunol. 38, 567–595 (2020).
Google Scholar
Man, S. M. & Kanneganti, T.-D. Converging roles of caspases in inflammasome activation, cell death and innate immunity. Nat. Rev. Immunol. 16, 7–21 (2015).
Google Scholar
Bertheloot, D., Latz, E. & Franklin, B. S. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell. Mol. Immunol. 18, 1106–1121 (2021).
Google Scholar
Peltzer, N. & Walczak, H. Cell death and inflammation—a vital but dangerous liaison. Trends Immunol. 40, 387–402 (2019).
Google Scholar
Newton, K., Strasser, A., Kayagaki, N. & Dixit, V. M. Cell death. Cell 187, 235–256 (2024).
Google Scholar
Liu, M. et al. A transistor-like pH-sensitive nanodetergent for selective cancer therapy. Nat. Nanotechnol. 17, 541–551 (2022).
Google Scholar
Shen, W. et al. Antineoplastic drug-free anticancer strategy enabled by host-defense-peptides-mimicking synthetic polypeptides. Adv. Mater. 32, e2001108 (2020).
Google Scholar
Xiong, M. et al. Selective killing of Helicobacter pylori with pH-responsive helix-coil conformation transitionable antimicrobial polypeptides. Proc. Natl Acad. Sci. USA 114, 12675–12680 (2017).
Google Scholar
Shao, N. et al. Heterochiral β-peptide polymers combating multidrug-resistant cancers effectively without inducing drug resistance. J. Am. Chem. Soc. 144, 7283–7294 (2022).
Google Scholar
Liu, L. et al. Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent. Nat. Nanotechnol. 4, 457–463 (2009).
Google Scholar
Wang, J. et al. pH-ultrasensitive membranolytic polyesters with alternating sequence of ionizable and hydrophobic groups for selective oncolytic therapy. J. Am. Chem. Soc. 147, 1008–1016 (2025).
Google Scholar
Forveille, S. et al. The oncolytic peptide LTX-315 triggers necrotic cell death. Cell Cycle 14, 3506–3512 (2015).
Google Scholar
Yamazaki, T. et al. The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade. Cell Death Differ. 23, 1004–1015 (2016).
Google Scholar
Xiong, M. et al. Bacteria-assisted activation of antimicrobial polypeptides by a random-coil to helix transition. Angew. Chem. Int. Ed. 56, 10826–10829 (2017).
Google Scholar
Qi, G. B., Zhang, D., Liu, F. H., Qiao, Z. Y. & Wang, H. An “on–site transformation” strategy for treatment of bacterial infection. Adv. Mater. 29, 1703461 (2017).
Google Scholar
Zhang, W. et al. The relationship between in vivo toxicity and responsive pH in transistor-like pH-sensitive nanodetergents. Small Methods 9, 2401263 (2025).
Google Scholar
Boedtkjer, E. & Pedersen, S. F. The acidic tumor microenvironment as a driver of cancer. Annu. Rev. Physiol. 82, 103–126 (2020).
Google Scholar
Du, J.-Z., Li, H.-J. & Wang, J. Tumor-acidity-cleavable maleic acid amide (TACMAA): a powerful tool for designing smart nanoparticles to overcome delivery barriers in cancer nanomedicine. Acc. Chem. Res. 51, 2848–2856 (2018).
Google Scholar
Settembre, C. & Perera, R. M. Lysosomes as coordinators of cellular catabolism, metabolic signalling and organ physiology. Nat. Rev. Mol. Cell Biol. 25, 223–245 (2024).
Google Scholar
Aits, S. et al. Sensitive detection of lysosomal membrane permeabilization by lysosomal galectin puncta assay. Autophagy 11, 1408–1424 (2015).
Google Scholar
Skowyra, M. L., Schlesinger, P. H., Naismith, T. V. & Hanson, P. I. Triggered recruitment of ESCRT machinery promotes endolysosomal repair. Science 360, eaar5078 (2018).
Google Scholar
Wang, F., Gómez-Sintes, R. & Boya, P. Lysosomal membrane permeabilization and cell death. Traffic 19, 918–931 (2018).
Google Scholar
Liu, H. et al. From oncolytic peptides to oncolytic polymers: a new paradigm for oncotherapy. Bioact. Mater. 31, 206–230 (2024).
Google Scholar
Galluzzi, L., Guilbaud, E., Schmidt, D., Kroemer, G. & Marincola, F. M. Targeting immunogenic cell stress and death for cancer therapy. Nat. Rev. Drug Discov. 23, 445–460 (2024).
Google Scholar
Kim, J., Eygeris, Y., Ryals, R. C., Jozić, A. & Sahay, G. Strategies for non-viral vectors targeting organs beyond the liver. Nat. Nanotechnol. 19, 428–447 (2024).
Google Scholar
Wang, Q. et al. Commensal-driven serotonin production modulates in vivo delivery of synthetic and viral vectors. Science 391, eadu7686 (2026).
Google Scholar
Duong, E. et al. Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity. Immunity 55, 308–323 (2022).
Google Scholar
Peng, F. et al. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct. Target. Ther. 7, 286 (2022).
Google Scholar
Zhang, J. et al. Tandem-controlled lysosomal assembly of nanofibres induces pyroptosis for cancer immunotherapy. Nat. Nanotechnol. 20, 563–574 (2025).
Google Scholar
Gemingnuer, A., Yin, R., Liu, Y., Tian, Y. & Meng, X. Lysosome-dependent cell death: disease implications and potential therapeutic targets. Mol. Biol. Rep. 52, 881 (2025).
Google Scholar
Kroemer, G., Galassi, C., Zitvogel, L. & Galluzzi, L. Immunogenic cell stress and death. Nat. Immunol. 23, 487–500 (2022).
Google Scholar
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L. & Kroemer, G. Immunogenic cell death in cancer and infectious disease. Nat. Rev. Immunol. 17, 97–111 (2016).
Google Scholar
Xiong, M. et al. Helical antimicrobial polypeptides with radial amphiphilicity. Proc. Natl Acad. Sci. USA 112, 13155–13160 (2015).
Google Scholar
Lu, H. et al. Ionic polypeptides with unusual helical stability. Nat. Commun. 2, 206 (2011).
Google Scholar
Zhang, Y. et al. SAGE1: a potential target antigen for lung cancer T-cell immunotherapy. Mol. Cancer Ther. 20, 2302–2313 (2021).
Google Scholar
Rapoport, A. P. et al. NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma. Nat. Med. 21, 914–921 (2015).
Google Scholar
Tomayko, M. M. & Reynolds, C. P. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother. Pharmacol. 24, 148–154 (1989).
Google Scholar
Check back often for more exciting news!
